Jland Biotech adds new collagen

China’s Jland Biotech is adding Biollagen-Lipo, a liposome-encapsulated grade of collagen. This is of non-animal origin and as such has no virus risk, low immunogenicity, no allergenicity, no rejection risk and good biocompatibility

China’s Jland Biotech is adding Biollagen-Lipo, a liposome-encapsulated grade, to its existing range of collagens. This is of non-animal origin and as such has no virus risk, low immunogenicity, no allergenicity, no rejection risk and good biocompatibility, the company said.

“The use of liposome encapsulation technology developed by JLand to wrap Biollagen SSE collagen leads to superior performance and has the obvious advantages of faster transdermal adsorption, stronger stability, slower release and longer acting, lower effective dose and reduced systemic adsorption,” the company added.

Latest Issues

IFSCC Congress 2025

Palais des Festivals, Cannes
15th - 18th September 2025

SEPAWA Congress 2025

ECC Estrel Center, Berlin
15-17th October 2025